Frank Westermann
Impact in
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Neurology top 0.2%
- Neuroblastoma Research and Treatments
Papers in
- Neurology 82
- Neuroblastoma Research and Treatments 82
-
- Protein Degradation and Inhibitors 15
- Signaling Pathways in Disease 10
- Cancer therapeutics and mechanisms 9
- Ubiquitin and proteasome pathways 8
- Histone Deacetylase Inhibitors Research 8
- Co-authors
- Manfred Schwab (29 shared papers)Frank Berthold (21 shared papers)Jo Vandesompele (11 shared papers)Daniel Muth (10 shared papers)Frank Speleman (13 shared papers)Pieter Mestdagh (7 shared papers)Javed Khan (7 shared papers)Jun S. Wei (7 shared papers)
- Journals
- Cancer Letters (9 papers)Cancer Research (8 papers)Oncogene (8 papers)Clinical Cancer Research (7 papers)Nature Genetics (4 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Frank Westermann
116 papers receiving 8.8k citations
Frank Westermann's Hit Papers
Peers
Comparison fields: 5 of 176
- Cancer Research 2.7k
- Neurology 2.4k
- Molecular Biology 5.6k
- Oncology 1.2k
- Cell Biology 368
Countries citing papers authored by Frank Westermann
This map shows the geographic impact of Frank Westermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Westermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Westermann more than expected).
Fields of papers citing papers by Frank Westermann
This network shows the impact of papers produced by Frank Westermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Westermann. The network helps show where Frank Westermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Westermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks Hit paper breakdown → | 2001 | 1927 |
| 2 | miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Hit paper breakdown → | 2010 | 1111 |
| 3 | A novel and universal method for microRNA RT-qPCR data normalization Hit paper breakdown → | 2009 | 849 |
| 4 | 2008 | 323 | |
| 5 | 2003 | 233 | |
| 6 | 2006 | 200 | |
| 7 | 2008 | 185 | |
| 8 | 2001 | 183 | |
| 9 | 2013 | 164 | |
| 10 | 2021 | 158 | |
| 11 | 2004 | 141 | |
| 12 | 2002 | 135 | |
| 13 | 2011 | 131 | |
| 14 | 2015 | 118 | |
| 15 | 2009 | 103 | |
| 16 | 2017 | 88 | |
| 17 | 2019 | 88 | |
| 18 | 2014 | 87 | |
| 19 | 2001 | 79 | |
| 20 | 2013 | 76 |
About Frank Westermann
Frank Westermann is a scholar working on Neurology, Molecular Biology, Cancer Research, Oncology and Cell Biology, having authored 118 papers that have together received 9.0k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (82 papers), Cancer, Hypoxia, and Metabolism (23 papers), Protein Degradation and Inhibitors (15 papers), Signaling Pathways in Disease (10 papers), Cancer therapeutics and mechanisms (9 papers), Ubiquitin and proteasome pathways (8 papers), Cancer-related Molecular Pathways (8 papers) and Histone Deacetylase Inhibitors Research (8 papers). The work is most often cited by research in Cancer Research (2.7k citations), Neurology (2.4k citations), Molecular Biology (5.6k citations), Oncology (1.2k citations) and Cell Biology (368 citations). Frank Westermann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Manfred Schwab, Frank Berthold, Jo Vandesompele, Daniel Muth, Frank Speleman, Pieter Mestdagh, Javed Khan, Jun S. Wei, Markus Ringnér and Lao H. Saal. Their work appears in journals such as Cancer Letters, Cancer Research, Oncogene, Clinical Cancer Research and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.